Cargando…
Posttraumatic midazolam administration does not influence brain damage after experimental traumatic brain injury
BACKGROUND: The benzodiazepine midazolam is a γ-aminobutyric acid (GABA)-A receptor agonist frequently used for sedation or stress control in patients suffering from traumatic brain injury (TBI). However, experimental studies on benzodiazepines have reported divergent results, raising concerns about...
Autores principales: | Sebastiani, Anne, Bender, Simone, Schäfer, Michael K. E., Thal, Serge C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896377/ https://www.ncbi.nlm.nih.gov/pubmed/35246037 http://dx.doi.org/10.1186/s12871-022-01592-x |
Ejemplares similares
-
AT2 activation does not influence brain damage in the early phase after experimental traumatic brain injury in male mice
por: Timaru-Kast, Ralph, et al.
Publicado: (2022) -
Single Administration of Tripeptide α-MSH(11–13) Attenuates Brain Damage by Reduced Inflammation and Apoptosis after Experimental Traumatic Brain Injury in Mice
por: Schaible, Eva-Verena, et al.
Publicado: (2013) -
Sequestosome 1 Deficiency Delays, but Does Not Prevent Brain Damage Formation Following Acute Brain Injury in Adult Mice
por: Sebastiani, Anne, et al.
Publicado: (2017) -
AT 1 inhibition mediated neuroprotection after experimental traumatic brain injury is dependent on neutrophils in male mice
por: Timaru-Kast, Ralph, et al.
Publicado: (2023) -
Early DNase-I therapy delays secondary brain damage after traumatic brain injury in adult mice
por: Krämer, Tobias J., et al.
Publicado: (2023)